Measurement of 232Th(p, x)225Ac reaction cross section at CSNS APEP facility up to 80 MeV
摘要
The radioisotope actinium-225 (225Ac) has been successfully used for targeted alpha therapy in preclinical and clinical applications because of its excellent nuclear characteristics. Medium- and high-energy proton-spallation reactions on thorium are the most important methods for producing 225Ac. This study examines the possibility of producing 225Ac by irradiating thorium oxide with medium-energy protons. Thorium-oxide sheets were irradiated with 40-, 50-, 60-, 70-, and 80-MeV protons on the Associated Proton-beam Experiment Platform (APEP) of the China Spallation Neutron Source (CSNS). The cross sections for the formation of 225Ac were measured using the activation method and offline gamma-ray spectrometric technique. The experimental results were compared with the existing data from EXFOR as well as the theoretical data from the TALYS-based evaluated nuclear-data library. Based on the experimental cross section and theoretical calculations, the production yield of 225Ac in the irradiated thorium targets was examined. The results showed that APEP can produce sufficient quantities of 225Ac for purification and clinical therapy. This work is the first measurement of proton-induced nuclear-reaction cross sections at the CSNS APEP.